Medical/Pharmaceuticals
H3C Makes Its Debut at International Modern Hospital Show 2022, Empowering Smart Healthcare
TOKYO, July 19, 2022 /PRNewswire/ -- The International Modern Hospital Show 2022 (IMHS 2022) officially kicked off inTokyo on July 13. By showcasing medical devices, medical information systems and healthcare services, the exhibition serves as a platform where global experts can discuss ways to ...
2022-07-19 20:14
2830
PeriGen Applauded by Frost & Sullivan for Its Innovative Perinatal Software Solutions for Fetal Monitoring and Clinical Decision Support
PeriGen's perinatal information systems provide the most accurate and holistic approach for monitoring infant and maternal health, enhancing clinical efficiency, allowing timely intervention, and promoting standardized care. SAN ANTONIO, July 19, 2022 /PRNewswire/ -- Recently, Frost & Sullivan r...
2022-07-19 20:00
2141
Seegene launches world's first In-life PCR campaign in Vietnam
* Test center LabHouse and ride-hailing service Grab to start PCR testing for Grab drivers in August * Seegene to provide Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay to simultaneously detect COVID-19, flu, cold * Testing to begin with drivers in Ho Chi Minh, Hanoi and will later be expanded to ...
2022-07-19 18:43
2609
Oncoshot Enters Collaboration Agreement With Omico (Australian Genomic Cancer Medicine Centre)
SINGAPORE, July 19, 2022 /PRNewswire/ – Oncoshot has just entered into a collaboration agreement with Omico, the Australian Genomic Cancer Medicine Centre. The respective parties were represented at the event yesterday by Dr Huren Sivaraj, CEO and co-founder of Oncoshot, and Prof David Thomas, ...
2022-07-19 18:30
3320
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore
* This investment will establish a cutting-edge, fully integrated CRDMO center inSingapore, including a research and development service center and large-scale drug substance and drug product manufacturing facilities for biologics * The investment strengthens WuXi Biologics' global research, ...
2022-07-19 18:03
3662
Antengene Announces Research Collaboration with Celularity to Evaluate the Potential Therapeutic Synergy of Combining Antengene's Best-in-Class Bispecific Antibody with Celularity's Natural Killer Cell Platform
- This research collaboration marks Antengene's entry into the field of cellular medicines. SHANGHAI and HONG KONGJuly 19, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discover...
2022-07-19 18:00
2967
WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation
SINGAPORE, July 19, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry, today announced a plan to build a new R&D and manufacturing site inSingapore. The company intends to invest up to S$2 bi...
2022-07-19 17:59
5955
DarwinHealth Publishes Results of Novel, Viral Checkpoint-based Technology for Predicting Drugs that Inhibit SARS-CoV-2 Replication: Global Collaboration Highlights Generalizability of Reported ViroTreat Model for Host Cell-Directed Antiviral Drug Discovery, the Role of Master Regulator Proteins, and Application to other Viral Pathogens and Pandemic Response
NEW YORK, July 19, 2022 /PRNewswire/ -- DarwinHealth, Inc., a New York-based biotechnology and cancer drug discovery company announces theJuly 19, 2022 online publication in Communications Biology (a Nature Portfolio peer-reviewed journal) of a foundational paper focused on new approaches to anti...
2022-07-19 17:00
3028
Guo Guangchang Visits Fosun's Member Companies in Hamburg, Germany and Meets Carola Veit, President of Hamburg Parliament
HONG KONG, July 19, 2022 /PRNewswire/ -- On 18 July 2022, Mr. Guo Guangchang, Chairman of Fosun International, and his delegation visited Yuyuan inHamburg, and German lifestyle fashion brandTom Tailor. He also met and had lunch with Ms. Carola Veit, President of the Hamburg Parliament. Mr. Marco W...
2022-07-19 15:55
5342
World Brain Day 2022 Will Feature Leading Experts to Promote Brain Health
LONDON, July 20, 2022 /PRNewswire/ -- July 22 is devoted to Brain Health for All for World Brain Day (WBD). This year, in a free webinar, the World Federation of Neurology (WFN) is featuring leading experts from regional and global organizations who are prioritizing brain health, including the Wor...
2022-07-19 13:00
2187
Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group to Advance the Commercialization of Long-acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The amubarvimab/romlusevimab combination is the first locally-discovered and approved SARS-CoV-2 target-specific treatment inChina, evaluated through a rand...
2022-07-19 12:34
5122
Significant Glycemic Control and Weight Loss: Innovent Announces Phase 2 Study of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Met Primary Endpoint
SAN FRANCISCO and SUZHOU, China, July 19, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and o...
2022-07-19 08:00
5238
SHL Medical announces plans for a new manufacturing site in the US
NORTH CHARLESTON, S.C., July 18, 2022 /PRNewswire/ -- SHL Medical (hereinafter referred to as "SHL") has revealed plans for a new manufacturing site in the US, in response to the growing market demand for its autoinjector product portfolio. The decision stems from SHL's strategic assessments in e...
2022-07-18 22:45
4689
BRONCUS COMPLETED SURGERIES ON THE FIRST GROUP OF PATIENTS USING ITS InterVapor®, THE THERMAL VAPOR TREATMENT SYSTEM, AFTER APPROVED FOR MARKETING IN CHINA
HANGZHOU, China, July 18, 2022 /PRNewswire/ -- Broncus Medical (02216.HK) has completed surgeries on the first group of patients using its InterVapor® (including InterVapor Generator and InterVapor Catheter, the "InterVapor®"), after it was approved for marketing inChina. This marked the official ...
2022-07-18 18:11
3719
Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics
Kinpeygo® (developed under the name NEFECON) is the first and only EMA- approved treatment for IgAN Everest Medicines has exclusive rights to develop and commercialize NEFECON in Greater China, Singapore and South Korea SHANGHAI, July 18, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Ev...
2022-07-18 08:00
4859
Amaris B. Clinic Is Seeing More Patients for Liposuction Due To Inefficacy of Non-surgical Fat Reduction Treatments
Dr Ivan Puah, Medical Director at Amaris B. Clinic, has been performing modern liposuction and corrective surgeries for patients who have experienced less than satisfactory results from non-surgical treatments and those who suffer from PAH, a rare side effect of cryolipolysis. SINGAPORE, Ju...
2022-07-17 10:42
4575
CStone Announces the NDA Approval of GAVRETO® (pralsetinib) for the Treatment of RET Fusion-Positive treatment-naïve (first-line) and pretreated Non-Small Cell Lung Cancer (NSCLC) in Hong Kong, China
* GAVRETO is the first highly selective rearranged during transfection (RET) inhibitor approved inHong Kong, China for the treatment of RET fusion-positive metastatic non-small cell lung cancer * GAVRETO is CStone's second therapy approved in Hong Kong, China * GAVRETO is CStone's ninth NDA ...
2022-07-15 08:02
5177
Zymo Research's DNA/RNA Shield™ Inactivates Monkeypox for the Collection and Transportation of Samples
IRVINE, Calif., July 15, 2022 /PRNewswire/ -- Zymo Research Corp., in collaboration with the Institute of Virology, University Medical Center Freiburg,Germany, demonstrated data showing their DNA/RNA Shield™ Inactivating Transport Medium (ITM) completely inactivated recent Monkeypox virus isolate...
2022-07-15 06:42
4807
Urgent support needed following the pandemic's effect on cancer screening services
Dry July call to arms will improve support for cancer patients SYDNEY, July 14, 2022 /PRNewswire/ -- Dry July Foundation is urging Australians to dig even deeper this Dry July to help people affected by cancer. So many Australians could not access vital lifesaving cancer screenings and treatment...
2022-07-14 17:19
3725
Tianlong launched a campaign to care for SMA children
XI'AN China, July 14, 2022 /PRNewswire/ -- Tianlong has launched a campaign together with the Spinal muscular atrophy (SMA) care center inChina (a non-profit organization for SMA), and The Second Affiliated Hospital of Xi'an Jiaotong University to care for children with SMA inMay 2022. Spinal mu...
2022-07-14 16:08
4108
Week's Top Stories
Most Reposted
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 280 media titles]
2026-09-28 23:04
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 279 media titles]
2026-09-29 09:00
Allianz Partners unveils next-generation travel insurance platform to help partners navigate changing landscape
[Picked up by 269 media titles]
2026-09-28 07:30
ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 267 media titles]
2026-09-30 10:50
Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 267 media titles]
2026-10-01 10:00
Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
17679
ULTRALOQ Launches Next-Generation Smart Lock Collection: Refining Home Entry with Natural, Intelligent and Trusted Access Solutions
2026-09-26 02:46
12275
MAYPHARM Unveils HYALMASS AQUATOX, a Next-Generation Multi-Active Skin Solution for the Global Aesthetic Market
2026-09-26 08:55
9548
